Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy

Leuk Lymphoma. 2008 Oct;49(10):2012-4. doi: 10.1080/10428190802290660.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Boronic Acids / therapeutic use
  • Bortezomib
  • Dexamethasone / therapeutic use
  • Doxorubicin / therapeutic use
  • Female
  • Humans
  • Leukemia, Plasma Cell / drug therapy*
  • Male
  • Middle Aged
  • Pyrazines / therapeutic use
  • Remission Induction / methods
  • Treatment Outcome

Substances

  • Boronic Acids
  • Pyrazines
  • Bortezomib
  • Dexamethasone
  • Doxorubicin